Markets:

Overview

News

Currencies

International

Treasuries

Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

45.53 -0.26 (-0.57%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Royalty Pharma plc - Class A Ordinary Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million

May 28, 2024

From Royalty Pharma plc

Via GlobeNewswire

Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe ↗

May 23, 2024

Unlock the latest on Royalty Pharma plc & Cytokinetics Inc.'s strategic funding collaboration for aficamten's commercialization and cardiovascular pipeline expansion.

Via Benzinga

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

May 22, 2024

From Royalty Pharma plc; Cytokinetics

Via GlobeNewswire

7 Dividend Stocks to Buy at a 52-Week Low ↗

May 20, 2024

For steady yields, not to mention rebound potential, consider the following seven dividend stocks at a 52-week low.

Via InvestorPlace

NASDAQ:RPRX: good value for what you're paying. ↗

April 24, 2024

Investors should take notice ofROYALTY PHARMA PLC- CL A (NASDAQ:RPRX)—it offers a great deal for the fundamentals it presents.

Via Chartmill

Looking Into Royalty Pharma's Recent Short Interest ↗

April 04, 2024

Via Benzinga

NASDAQ:RPRX is an undervalued gem with solid fundamentals. ↗

March 29, 2024

ROYALTY PHARMA PLC- CL A (NASDAQ:RPRX), an undervalued stock with good fundamentals.

Via Chartmill

Royalty Pharma to Present at Upcoming Investor Conferences

May 13, 2024

From Royalty Pharma plc

Via GlobeNewswire

RPRX Stock Earnings: Royalty Pharma Misses EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

RPRX stock results show that Royalty Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

Royalty Pharma Reports First Quarter 2024 Results

May 09, 2024

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

May 09, 2024

From Royalty Pharma plc

Via GlobeNewswire

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

Royalty Pharma's Earnings: A Preview ↗

February 14, 2024

Via Benzinga

Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment ↗

May 02, 2024

Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company said EPS decreased by 1% due to higher operating and interest expenses...

Via Benzinga

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024

April 19, 2024

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma Declares Second Quarter 2024 Dividend

April 17, 2024

From Royalty Pharma plc

Via GlobeNewswire

3 Pharma Stocks to Sell in April Before They Crash & Burn ↗

April 11, 2024

Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside.

Via InvestorPlace

Billionaire Bargain Bin: 3 Stocks the Forbes 400 Loves (That You’ve Never Heard Of) ↗

April 09, 2024

These Forbes 400 stocks have wealthy founders who run them with little fanfare or attention but are worth considering for your portfolio.

Via InvestorPlace

April’s Hidden Gems: 3 Overlooked Stocks to Freshen Up Your Portfolio ↗

April 09, 2024

Discover three overlooked stocks on Wall Street with the potential for growth and diversification this April.

Via InvestorPlace

The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio ↗

March 27, 2024

With a possible rotation away from the technology space, these are the undervalued healthcare stocks to consider.

Via InvestorPlace

For those who appreciate value investing, NASDAQ:RPRX is a compelling option with its solid fundamentals. ↗

February 29, 2024

When you look at ROYALTY PHARMA PLC- CL A (NASDAQ:RPRX), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.

Via Chartmill

Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference

February 28, 2024

From Royalty Pharma plc

Via GlobeNewswire

Wall Street Thinks These 3 Stocks Are Hidden Gems That Could Soar 43% to 59% Over the Next 12 Months ↗

February 16, 2024

Analysts are quite bullish about these beaten-down stocks.

Via The Motley Fool

Royalty Pharma Reports Q4 and Full Year 2023 Results

February 15, 2024

From Royalty Pharma plc

Via GlobeNewswire

3 Biotech Stocks to Buy for the Next Bull Run: February 2024 ↗

February 08, 2024

These are the biotech stocks to buy that you must have on your watchlist for the coming bull run. It could get started as soon as this month.

Via InvestorPlace

NASDAQ:RPRX is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. ↗

February 08, 2024

ROYALTY PHARMA PLC- CL A (NASDAQ:RPRX) is an undervalued gem with solid fundamentals.

Via Chartmill

How Risky Is Royalty Pharma’s Dividend? ↗

February 07, 2024

Royalty Pharma just announced a 5% dividend increase, its fourth raise in a row. It has boosted the dividend every year since it began paying one in 2020. The new $0.21 per share quarterly dividend...

Via Talk Markets

Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024

January 30, 2024

From Royalty Pharma plc

Via GlobeNewswire

Top Stocks That Just Increased Their Dividends ↗

January 23, 2024

There are several reasons why investors tend to favor stocks that have had a dividend increase.

Via Talk Markets

Royalty Pharma Announces Dividend Increase

January 19, 2024

From Royalty Pharma plc

Via GlobeNewswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.